Hsuan-Pei Lin

469 citations
14 papers · 380 indexed · h-index 12
Topics
Cancer Cells and Metastasis (5 papers)Chromium effects and bioremediation (3 papers)Hedgehog Signaling Pathway Studies (2 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Hsuan-Pei Lin

14 papers receiving 379 citations

Peers

Hsuan-Pei Lin
Comparison fields: 5 of 70
  • Molecular Biology 229
  • Cancer Research 108
  • Oncology 90
  • Biomedical Engineering 65
  • Health, Toxicology and Mutagenesis 61
Replace Olga Bajenova with:
Olga Bajenova United States
Nafis Hasan United States
Seogho Son South Korea
Shibo Ying China
Chang‐Woo Song South Korea
Xuetong Wang China
Zhiqin Fu China
Zahraa I. Khamis United States
Maria Kovalenko United States
Shirin Hafezi United Arab Emirates
Hsuan-Pei Lin relative to Olga Bajenova United States Olga Bajenova's profile →
Citations per field
00.5×5.6×
Olga Bajenova · 1×
Citations per year

Countries citing papers authored by Hsuan-Pei Lin

Since Specialization
Citations

This map shows the geographic impact of Hsuan-Pei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsuan-Pei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsuan-Pei Lin more than expected).

Fields of papers citing papers by Hsuan-Pei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsuan-Pei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsuan-Pei Lin. The network helps show where Hsuan-Pei Lin may publish in the future.

Co-authorship network of co-authors of Hsuan-Pei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hsuan-Pei Lin. A scholar is included among the top collaborators of Hsuan-Pei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsuan-Pei Lin. Hsuan-Pei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 9
3 19
4 23
5 47
6 15
7 25
8 19
9 21
10 38
11 42
12 18
13 89
14 14

About Hsuan-Pei Lin

Hsuan-Pei Lin is a scholar working on Immunology and Allergy, Oncology and Health, Toxicology and Mutagenesis, having authored 14 papers that have together received 380 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Chromium effects and bioremediation (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Cancer Research (108 citations), Immunology and Allergy (28 citations) and Health, Toxicology and Mutagenesis (61 citations). Hsuan-Pei Lin has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Chengfeng Yang, Zhishan Wang, Jie Xie, Ping Yang, Yajuan Xiao, Yiguo Jiang, Xuefei Huang, Yunfei Li, Yunfei Li and Derek Reichel. Their work appears in journals such as PLoS ONE, Biomaterials and Environmental Pollution.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026